Ebrahimi, H.; Battle, D.; Salgia, N.J.; Zengin, Z.B.; Dizman, N.; Meza, L.; Bergerot, C.D.; Barragan-Carrillo, R.; Hsu, J.; Castro, D.;
et al. Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients 2024, 16, 1630.
https://doi.org/10.3390/nu16111630
AMA Style
Ebrahimi H, Battle D, Salgia NJ, Zengin ZB, Dizman N, Meza L, Bergerot CD, Barragan-Carrillo R, Hsu J, Castro D,
et al. Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients. 2024; 16(11):1630.
https://doi.org/10.3390/nu16111630
Chicago/Turabian Style
Ebrahimi, Hedyeh, Dena Battle, Nicholas J. Salgia, Zeynep B. Zengin, Nazli Dizman, Luis Meza, Cristiane D. Bergerot, Regina Barragan-Carrillo, JoAnn Hsu, Daniela Castro,
and et al. 2024. "Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy" Nutrients 16, no. 11: 1630.
https://doi.org/10.3390/nu16111630
APA Style
Ebrahimi, H., Battle, D., Salgia, N. J., Zengin, Z. B., Dizman, N., Meza, L., Bergerot, C. D., Barragan-Carrillo, R., Hsu, J., Castro, D., Mercier, B., Chawla, N., Li, X., Tripathi, A., Liu, S. T., Chehrazi-Raffle, A., Vaishampayan, U., Staehler, M. D., & Pal, S. K.
(2024). Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients, 16(11), 1630.
https://doi.org/10.3390/nu16111630
